BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10429)

  • 1. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains.
    Brase DA; Loh HH; Way EL
    J Pharmacol Exp Ther; 1977 May; 201(2):368-74. PubMed ID: 558328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
    Iorio LC; Deacon MA; Ryan EA
    J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pargyline on morphine tolerance and physical dependence development in mice.
    Iwamoto ET; Ho IK; Way EL
    Eur J Pharmacol; 1976 Aug; 38(2):261-8. PubMed ID: 986307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1975 Jul; 194(1):65-73. PubMed ID: 1171222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
    Lange DG; Roerig SC; Fujimoto JM; Busse LW
    J Pharmacol Exp Ther; 1983 Jan; 224(1):13-20. PubMed ID: 6681541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice.
    Pourmotabbed A; Rostamian B; Manouchehri G; Pirzadeh-Jahromi G; Sahraei H; Ghoshooni H; Zardooz H; Kamalnegad M
    J Ethnopharmacol; 2004 Dec; 95(2-3):431-5. PubMed ID: 15507371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of mice to naloxone induced jumping after a single narcotic injection: effect of prior physical dependence.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    Proc West Pharmacol Soc; 1975; 18():294-7. PubMed ID: 1237142
    [No Abstract]   [Full Text] [Related]  

  • 20. Antinociceptive effects of lanthanum and cerium in nontolerant and morphine tolerant-dependent animals.
    Harris RA; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Feb; 196(2):288-97. PubMed ID: 176345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.